← Back to Search

Other

[14C]BMS-986419 for Healthy Subjects

Phase 1

Waitlist Available

Research Sponsored by Bristol-Myers Squibb

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to day 60

Awards & highlights

Study Summary

This trial tests how a drug is processed in the body, how it's eliminated, and how safe and tolerable it is in healthy men.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to day 60

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to day 60

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 60 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Area under the plasma concentration-time curve from time zero to time of last quantifiable concentration (AUC [0-T])

Maximum observed plasma concentration (Cmax)

Percent of total radioactivity recovered (%Total)

+7 more

Secondary outcome measures

Number of Participants with AEs leading to discontinuation

Number of Participants with Adverse Events (AEs)

Number of Participants with Clinical Laboratory Abnormalities

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: [14C]BMS-986419Experimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

[14C]BMS-986419

2023

Completed Phase 1

~10

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor

2,641 Previous Clinical Trials

4,130,056 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria are being used to select participants for this trial?

"To be included in this research study, individuals must meet the criteria of being aged 18 to 55 and have no pre-existing medical issues. Only 8 participants can partake in the venture."

Answered by AI

Are participants aged over 20 eligible to join this experimentation?

"This clinical trial is only open to patients between 18 and 55 years of age. Alternatively, there are 58 trials available for minors while 381 studies cater to senior citizens."

Answered by AI

What potential risks does [14C]BMS-986419 pose to patients?

"As this is a Phase 1 clinical trial, which involves limited data regarding safety and efficacy, [14C]BMS-986419 was assigned the lowest score of 1."

Answered by AI

Are there any openings left for participants in this study?

"Affirmative. Clinicaltrials.gov contains information that this research is actively recruiting participants. The trial was posted on May 5th 2023 and the latest update was made on May 24th, with 8 patients required from a single medical centre."

Answered by AI

How many participants are being administered this therapeutic experiment?

"Indeed, the information hosted on clinicaltrials.gov affirms that this medical trial is looking for volunteers. The study was initially posted on May 5th 2023 and recently amended on May 24th 2023. This investigation requires 8 participants from one location to take part in it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants

2023. "A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05847439.